Clinical Trials
16 trialsNCT06303687 2025-11-24
VR-PAT and fNIRS to Identify CNS Biomarkers of Pain
Nationwide Children's Hospital
Phase NA Not yet recruiting
NCT05549232 2025-07-23
Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital
Hemanext
Completed
NCT05019144 2025-07-11
TOBI
Medical University of South Carolina
Phase NA Completed
NCT05673551 2025-06-19
VR-PAT During Home Burn Dressings - Multisite
Nationwide Children's Hospital
Phase NA Enrolling by invitation
NCT06591195 2024-09-19
DISTRACT
Radboud University Medical Center
Phase NA Not yet recruiting
NCT05148390 2024-02-21
GELFI
BSN Medical GmbH
Completed
NCT06103409 2023-10-26
MSCs for the Treatment of Burn Wounds
Instituto Venezolano de Investigaciones Cientificas
Phase 1/2 Unknown
NCT03660618 2023-05-10
LSFG-SKIN, Laser Speckle Flowgraphy
University of Iowa
Phase NA Terminated
NCT01436292 2022-11-17
Halburns
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 4 Withdrawn
NCT00540566 2022-10-20
Optical Biopsy of Human Skin in Conjunction With Laser Treatment
University of California, Irvine
Completed
NCT02145130 2021-09-08
Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects
University of Zurich
Phase 1 Completed
NCT01574131 2019-11-29
Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients
The University of Texas Medical Branch, Galveston
Phase 4 Terminated
NCT03113747 2017-04-26
ADSCs-BWs
A.A. Partners, LLC
Phase 1/2 Unknown
NCT00236041 2014-05-09
Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed
NCT00236093 2014-05-09
Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed
NCT01302223 2012-12-06
Keratinocyte Growth Factor and Cytokines in Burns.
Federal University of São Paulo
Completed